Open AccessThis article is
- freely available
Pancreatic Cancer Biomarkers and Their Implication in Cancer Diagnosis and Epidemiology
Methods and Technologies Branch, Epidemiology and Genetics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institues of Health (NIH), 6130 Executive Blvd., Suite 5100. Bethesda, MD 20892-7324, USA
Received: 21 October 2010; Accepted: 29 October 2010 / Published: 2 November 2010
Abstract: Pancreatic cancer is the fourth most common cause of cancer-related mortality in the United States. Biomarkers are needed to detect this cancer early during the disease development and for screening populations to identify those who are at risk. In cancer, “biomarker” refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker might be either a molecule secreted by a tumor or it can be a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. A number of potential biomarkers have been identified for pancreatic cancer. These markers can be assayed in non-invasively collected biofluids. These biomarkers need analytical and clinical validation so that they can be used for the purpose of screening and diagnosing pancreatic cancer and determining disease prognosis. In this article, the latest developments in pancreatic cancer biomarkers are discussed.
Keywords: biomarker; cancer; diagnosis; epidemiology; epigenetics; glycans; methylation index; pancreas; prognosis; sensitivity; specificity; survival; treatment
Citations to this Article
Cite This Article
MDPI and ACS Style
Verma, M. Pancreatic Cancer Biomarkers and Their Implication in Cancer Diagnosis and Epidemiology. Cancers 2010, 2, 1830-1837.
Verma M. Pancreatic Cancer Biomarkers and Their Implication in Cancer Diagnosis and Epidemiology. Cancers. 2010; 2(4):1830-1837.
Verma, Mukesh. 2010. "Pancreatic Cancer Biomarkers and Their Implication in Cancer Diagnosis and Epidemiology." Cancers 2, no. 4: 1830-1837.